ArticleBlood cancer journal2018

Lenalidomide plus R-CHOP21 in newly diagnosed diffuse large B-cell lymphoma (DLBCL): long-term follow-up results from a combined analysis from two phase 2 trials.

A Castellino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.